![]()
Graeme N. Smith, M.D., Ph.D.
ProfessorDepartment of Obstetrics & Gynaecology
Division of Maternal-Fetal MedicineFellowship: Maternal-Fetal Medicine, University of Toronto, Ontario (1999)
Residency: Obstetrics & Gynaecology, Queen's University, Kingston, Ontario (1997)
Medical School Graduation: The University of Western Ontario (1992)
Postgraduate Training: The University of Western Ontario [John Patrick, Supervisor] (Ph.D. 1990)
Current Appointments: Cross-appointment to the Dept of Anatomy and Cell Biology, and the Dept of Pharmacology and Toxicology; Resident Research Coordinator (1999); Director, Perinatal Research Unit, Queen's University; Medical Co-advisor, Perinatal Partnership Program of Eastern Ontario (PPPESO) (2004)
Research Interests: Chorioamnionitis and fetal brain injury; tocolysis (treatment of preterm labour)
Other Interests: Ice climbing, triathlon competition.
Selected Publications:
Smith GN, Walker MC, Ohlsson A, O'Brien K, Windrim R; Canadian Preterm Labour Nitroglycerin Trial Group. Randomized double-blind placebo-controlled trial of transdermal nitroglycerinfor preterm labor. Am J Obstet Gynecol 2007 Jan;196(1):37.e1-8.
Bainbridge SA, Sidle EH, Smith GN. Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses 2005;64(1):17-27.
Patrick LA, Gaudet LM, Farley AE, Rossiter JP, Tomalty LL, Smith GN. Development of a guinea pig model of chorioamnionitis and fetal brain injury. Am J Obstet Gynecol 2004 Oct;191(4):1205-11.
Smith GN. What are the realistic expectations of tocolytics? [Review] BJOG. 2003 Apr;110 Suppl 20:103-6.
Smith GN, Kingdom JC, Penning DH, Matthews SG. Antenatal corticosteroids: Is more better?. Lancet 2000;355:251-2.
Smith GN, Walker M, McGrath MJ. Randomized, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br J Obstet Gynecol 1999;106:736-739.
Canadian Perinatal Network (www.perinet.org)